​​New booklet on ALK-positive lung cancer provides vital support for patients and caregivers

August 24, 2024
healthcaretoday, Lung cancer awareness, ALK positive lung cancer, cancer support, Early detection, cancer survival, targeted therapy, immunotherapy, radiotherapy, cancer treatment, lung cancer care, Health Malaysia, cancer education, cancer screening, medical advancements, patient empowerment, Thrive Campaign, National Cancer Society Malaysia,
(From left) Dr Murallitharan Munisamy; Managing Director of the National Cancer Society Malaysia, Dr Marfu'ah Nik Eezamuddeen; Consultant Oncologist and Dr Tho Lye Mun; President of the Lung Cancer Network Malaysia among others with the new booklet on ALK-positive lung cancer.
​​​The National Cancer Society Malaysia (NCSM) and Lung Cancer Network Malaysia (LCNM) have joined forces to create a vital resource for those newly diagnosed with ALK-positive lung cancer. This booklet, available in English, Bahasa Melayu, and Tamil, is designed to support patients and caregivers by providing detailed information on this specific lung cancer subtype, from understanding risk factors and symptoms to navigating diagnosis and treatment options. As part of the Thrive campaign, digital copies of the booklet can be easily accessed and downloaded, ensuring that essential information is readily available to those who need it.

The growing challenge of lung cancer in Malaysia
Lung cancer remains a significant health issue in Malaysia, ranking as the third most common cancer and the leading cause of cancer-related deaths. The statistics paint a grim picture, with up to 90% of lung cancer cases diagnosed at an advanced stage (stage 3 or 4). For these patients, the 5-year survival rate ranges between a sobering 6.3% and 7.5%, underscoring the critical need for early detection and effective treatment strategies.

Understanding ALK-positive lung cancer
Dr Marfuah Nik Eezamuddeen, a Consultant Oncologist, emphasizes the complexity of lung cancer, noting that it is not a single disease but a collection of subtypes, each with its unique challenges. ALK-positive lung cancer, a subtype of non-small cell lung cancer (NSCLC), is particularly notable for its aggressive nature and its tendency to affect younger individuals, including non-smokers. This contrasts with the common perception that lung cancer predominantly affects older, heavy smokers.

Data from the Malaysian Lung Cancer Registry, collected between 2015 and 2020, reveals that ALK-positive lung cancer affects a relatively small but significant portion of lung cancer patients, with 1,581 cases identified across 18 major public hospitals. Interestingly, the gender distribution among these patients is nearly equal, with 49% being male and 51% female. This subtype of lung cancer is driven by mutations in the anaplastic lymphoma kinase (ALK) gene, which can be found in approximately 5% of NSCLC cases.

Dr Tho Lye Mun, President of Lung Cancer Network Malaysia, highlights the advancements in medical innovation that have significantly improved outcomes for patients with ALK-positive NSCLC. These advancements have transformed a once bleak prognosis into one where long-term survival and quality of life are achievable goals.

The importance of early detection
One of the key messages in the battle against lung cancer is the importance of early detection. However, detecting lung cancer in its early stages remains a formidable challenge. This is partly due to the disease's subtle and often misleading symptoms, which can easily be mistaken for less serious conditions such as the common cold or chest infections. This delay in diagnosis can have devastating consequences, as the cancer may have already progressed to an advanced stage by the time it is accurately identified.

In recent years, technological advancements have offered new hope in the early detection of lung cancer. Dr Murallitharan Munisamy, Managing Director of the National Cancer Society Malaysia explains that AI-guided chest X-rays are emerging as a valuable tool in this regard. These X-rays, particularly when conducted with high-definition imaging, provide a more accurate and cost-effective method of screening for lung cancer, especially in populations where access to specialized diagnostic tools like CT scans may be limited.

The integration of AI in medical imaging represents a significant leap forward in the ability to detect lung cancer early. By improving the accuracy of chest X-rays, AI technology helps to overcome one of the major challenges in lung cancer detection: the operator-dependent nature of traditional imaging techniques. This advancement not only makes screening more accessible but also enhances the likelihood of catching the disease at a stage where treatment can be most effective.

Navigating treatment options
For patients diagnosed with ALK-positive lung cancer, the treatment landscape has evolved considerably over the past two decades. Targeted therapy, which involves the use of molecules designed to specifically attack the proteins produced by cancer-causing mutations, has revolutionized the treatment of this disease. Compared to traditional chemotherapy, targeted therapy offers a more precise and less toxic approach, significantly improving both survival rates and the quality of life for patients.

Dr Tho Lye Mun notes that the median overall survival for patients receiving ALK-directed treatments now extends beyond five years, a remarkable improvement from the bleak prognosis of just 20 years ago. In some cases, patients not only survive but thrive, enjoying a quality of life that would have been unimaginable in the past.

In addition to targeted therapy, other treatment modalities such as radiotherapy and immunotherapy play crucial roles in the management of ALK-positive lung cancer. Radiotherapy, particularly in its modern form of radiosurgery, offers a highly precise and minimally invasive option that can target tumors with minimal damage to surrounding tissues. This precision leads to faster recovery times and better outcomes for patients.

Immunotherapy, another groundbreaking approach, works by enhancing the body's immune response to cancer. Rather than directly targeting the tumor, immunotherapy modifies the interaction between the immune system and the cancer cells, empowering the body to fight the disease more effectively.

The importance of personalized medicine
A key takeaway from the ongoing battle against ALK-positive lung cancer is the critical importance of personalized medicine. As Dr Marfuah emphasizes, correctly identifying the genetic mutations driving a patient's cancer is essential to selecting the most effective treatment. Mismatching a patient with the wrong targeted therapy or treatment modality can have serious consequences, potentially reducing the patient's lifespan and complicating future treatment options.

The concept of personalized medicine extends beyond just selecting the right therapy. It involves a comprehensive approach to cancer care that takes into account the unique genetic and molecular characteristics of each patient's tumor. This approach ensures that treatment is tailored to the individual, maximizing the chances of success while minimizing the risk of adverse side effects.

Overcoming myths and misconceptions
Dr Murallitharan underscores the need to dispel common myths surrounding lung cancer. One of the most pervasive misconceptions is that lung cancer is solely a smoker's disease. While smoking is indeed a major risk factor, the rise in lung cancer cases among non-smokers, particularly younger women in Asia, challenges this outdated belief.

On the other hand, smokers may dismiss early symptoms of lung cancer as minor issues related to their smoking habit, leading to delays in seeking medical attention. This dual misconception—where non-smokers believe they are immune and smokers underestimate their risk—contributes to the high rate of late-stage diagnoses.

The road ahead: Screening and early intervention
To improve outcomes for lung cancer patients, particularly those with ALK-positive disease, it is imperative to focus on early detection and timely intervention. Dr Murallitharan urges individuals at high risk of developing lung cancer to undergo regular screening and to seek medical advice promptly if they experience symptoms. Early detection not only increases the chances of successful treatment but also prevents the cancer from spreading to other parts of the body, where it becomes more difficult to manage.

The newly developed booklet on ALK-positive lung cancer by NCSM and LCNM represents a significant step forward in supporting patients and caregivers. By providing clear, accessible information and promoting awareness of the importance of early detection and personalized treatment, this resource empowers individuals to take control of their cancer journey, offering hope in the face of a challenging diagnosis.

EXPLORE FURTHER

What is cancer and how does it spread?

​The differences between cancer cells and normal cells

Cancer: Different types and origins

​Categories that initiate within particular cell types.

What signs could signal cancer?

​Recognizing subtle clues from your body

Comprehensive guide to cancer screening: What you can expect

​Navigating initial screening apprehensions

How often should you be screened for cancer?

​Pre-cancer awareness and proper screening is vital

Cancer diagnostics: Tests and results explained

​Making sense of lab test, imaging test and biopsy

Overcoming fibromyxoid sarcoma against all odds

Neng would feel tickles down his throat, with itching and frequent coughs...

World Cancer Day: What will you do to close the care gap?

Social factors or lifestyle can negatively impact the quality of cancer care.

Fighting cervical cancer in the age of COVID-19

Second most common cancer despite it being a preventable disease.

​Below 15 exposed to sexual intercourse, at higher risk of developing cervical cancer

Oral contraceptives...

No alternative therapy, magic pill for cure, says breast cancer survivor

​"There wasn't any pain nor any changes to my breast, but I could feel the lump."

​Evolving treatment for metastatic colorectal cancer

Colorectal cancer is the most common cancer diagnosed in men

Locks of Hope: Empowering cancer patients with confidence and support

Free human-hair pieces to individuals battling cancer.

​Chemotherapy: Balancing efficacy and minimizing side effects

​​​For decades, chemotherapy has remained a cornerstone in cancer treatment...

​PET scans in prostate cancer detection

​​The risk of prostate cancer increases with age, and it often coexists with Benign Prostatic Hyperplasia (BPH)

Triumph over adversity: Stories of courage in the face of cancer

​Three inspiring individuals defying the odds

Can you be fired for having cancer?

​National Human Resource Centre says no provision in Employment Act for cancer 

Nutrition vs. dot-com doctors: Debunking cancer myths

​Cancer preventive tips from a nutritionist

How often should you be screened for cancer?

Pre-cancer awareness and proper screening is vital. ​

Cigarettes cause bladder cancer

​Smokers are four times more likely to develop bladder cancer than non-smokers.

Malaysia's cancer landscape: A closer look at incidence, trends and risk factors

​Changing cancer incidence patterns in Malaysia